Clinical Trials Logo

Neurotrophic Keratitis clinical trials

View clinical trials related to Neurotrophic Keratitis.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06364657 Not yet recruiting - Dry Eye Clinical Trials

Differences in Corneal Structure and Function in Patients With Sjogrens vs. Non-Sjogrens Dry Eye

IIR
Start date: July 1, 2024
Phase:
Study type: Observational

In this study the investigators plan to enroll three groups of patients: non-Sjogren's dry eye, Sjogren's dry eye and controls. The study has the following primary goals: 1. To determine whether dry eye is associated with reduced corneal sensation 2. To determine whether reduced corneal sensation is due to the severity of the dry eye, the type of dry eye (primarily aqueous deficient versus primarily evaporative) or entirely related to the presence of Sjogren's 3. To determine whether corneal sensation is associated with ocular or systemic pain symptoms Additionally, the study aims to compare the novel corneal esthesiometer measurements to confocal biomicroscopy findings in determining neurotrophic keratitis (NK) and assess correlations between corneal sensation.

NCT ID: NCT05927428 Not yet recruiting - Clinical trials for Neurotrophic Keratitis

Assessment of the Safety and Efficacy of BRM424 Ophthalmic Solutions in Patients With Neurotrophic Keratitis

Start date: September 30, 2023
Phase: Phase 2
Study type: Interventional

The objective of this study is to compare the safety and efficacy of BRM424 OS compared to vehicle in patients with neurotrophic keratitis.

NCT ID: NCT02707120 Not yet recruiting - Clinical trials for Neurotrophic Keratitis

Efficacy and Safety of Plasma Rich in Growth Factors (PRGF-Endoret) Eye-drops in the Treatment of Neurotrophic Keratitis

Start date: January 4, 2018
Phase: Phase 4
Study type: Interventional

Neurotrophic keratitis (NK) is a rare degenerative corneal disease caused by altered innervation of the trigeminal nerve that leads to rupture of the corneal epithelium, the regeneration deterioration and development of corneal ulceration, their fusion, and perforation The main characteristic in the NK is a decrease or absence of corneal sensitivity.